260 related articles for article (PubMed ID: 26899263)
1. Very early discharge versus early discharge versus non-early discharge in children with cancer and febrile neutropenia.
Loeffen EA; Te Poele EM; Tissing WJ; Boezen HM; de Bont ES
Cochrane Database Syst Rev; 2016 Feb; 2(2):CD008382. PubMed ID: 26899263
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Outpatient treatment for people with cancer who develop a low-risk febrile neutropaenic event.
Rivas-Ruiz R; Villasis-Keever M; Miranda-Novales G; Castelán-Martínez OD; Rivas-Contreras S
Cochrane Database Syst Rev; 2019 Mar; 3(3):CD009031. PubMed ID: 30887505
[TBL] [Abstract][Full Text] [Related]
4. Early discontinuation of antibiotics for febrile neutropenia versus continuation until neutropenia resolution in people with cancer.
Stern A; Carrara E; Bitterman R; Yahav D; Leibovici L; Paul M
Cochrane Database Syst Rev; 2019 Jan; 1(1):CD012184. PubMed ID: 30605229
[TBL] [Abstract][Full Text] [Related]
5. Low bacterial diet versus control diet to prevent infection in cancer patients treated with chemotherapy causing episodes of neutropenia.
van Dalen EC; Mank A; Leclercq E; Mulder RL; Davies M; Kersten MJ; van de Wetering MD
Cochrane Database Syst Rev; 2016 Apr; 4(4):CD006247. PubMed ID: 27107610
[TBL] [Abstract][Full Text] [Related]
6. Low bacterial diet versus control diet to prevent infection in cancer patients treated with chemotherapy causing episodes of neutropenia.
van Dalen EC; Mank A; Leclercq E; Mulder RL; Davies M; Kersten MJ; van de Wetering MD
Cochrane Database Syst Rev; 2012 Sep; (9):CD006247. PubMed ID: 22972091
[TBL] [Abstract][Full Text] [Related]
7. Prophylactic antibiotics or G(M)-CSF for the prevention of infections and improvement of survival in cancer patients receiving myelotoxic chemotherapy.
Skoetz N; Bohlius J; Engert A; Monsef I; Blank O; Vehreschild JJ
Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD007107. PubMed ID: 26687844
[TBL] [Abstract][Full Text] [Related]
8. Colony-stimulating factors for chemotherapy-induced febrile neutropenia.
Mhaskar R; Clark OA; Lyman G; Engel Ayer Botrel T; Morganti Paladini L; Djulbegovic B
Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD003039. PubMed ID: 25356786
[TBL] [Abstract][Full Text] [Related]
9. Rapid COJEC versus standard induction therapies for high-risk neuroblastoma.
Peinemann F; Tushabe DA; van Dalen EC; Berthold F
Cochrane Database Syst Rev; 2015 May; 2015(5):CD010774. PubMed ID: 25989478
[TBL] [Abstract][Full Text] [Related]
10. Early enteral nutrition within 24 hours of lower gastrointestinal surgery versus later commencement for length of hospital stay and postoperative complications.
Herbert G; Perry R; Andersen HK; Atkinson C; Penfold C; Lewis SJ; Ness AR; Thomas S
Cochrane Database Syst Rev; 2019 Jul; 7(7):CD004080. PubMed ID: 31329285
[TBL] [Abstract][Full Text] [Related]
11. Early enteral nutrition within 24 hours of lower gastrointestinal surgery versus later commencement for length of hospital stay and postoperative complications.
Herbert G; Perry R; Andersen HK; Atkinson C; Penfold C; Lewis SJ; Ness AR; Thomas S
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD004080. PubMed ID: 30353940
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy for children with medulloblastoma.
Michiels EM; Schouten-Van Meeteren AY; Doz F; Janssens GO; van Dalen EC
Cochrane Database Syst Rev; 2015 Jan; 1(1):CD006678. PubMed ID: 25879092
[TBL] [Abstract][Full Text] [Related]
13. Intracystic bleomycin for cystic craniopharyngiomas in children.
Zhang S; Fang Y; Cai BW; Xu JG; You C
Cochrane Database Syst Rev; 2016 Jul; 7(7):CD008890. PubMed ID: 27416004
[TBL] [Abstract][Full Text] [Related]
14. Medical interventions for the prevention of platinum-induced hearing loss in children with cancer.
van As JW; van den Berg H; van Dalen EC
Cochrane Database Syst Rev; 2019 May; 5(5):CD009219. PubMed ID: 31063591
[TBL] [Abstract][Full Text] [Related]
15. Probing for congenital nasolacrimal duct obstruction.
Petris C; Liu D
Cochrane Database Syst Rev; 2017 Jul; 7(7):CD011109. PubMed ID: 28700811
[TBL] [Abstract][Full Text] [Related]
16. Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients.
Vidal L; Ben Dor I; Paul M; Eliakim-Raz N; Pokroy E; Soares-Weiser K; Leibovici L
Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD003992. PubMed ID: 24105485
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic drug management for febrile seizures in children.
Offringa M; Newton R; Nevitt SJ; Vraka K
Cochrane Database Syst Rev; 2021 Jun; 6(6):CD003031. PubMed ID: 34131913
[TBL] [Abstract][Full Text] [Related]
18. Colony stimulating factors for prevention of myelosupressive therapy induced febrile neutropenia in children with acute lymphoblastic leukaemia.
Sasse EC; Sasse AD; Brandalise S; Clark OA; Richards S
Cochrane Database Syst Rev; 2005 Jul; (3):CD004139. PubMed ID: 16034921
[TBL] [Abstract][Full Text] [Related]
19. Intravenous immunoglobulin for the treatment of childhood encephalitis.
Iro MA; Martin NG; Absoud M; Pollard AJ
Cochrane Database Syst Rev; 2017 Oct; 10(10):CD011367. PubMed ID: 28967695
[TBL] [Abstract][Full Text] [Related]
20. Medical interventions for the prevention of platinum-induced hearing loss in children with cancer.
van As JW; van den Berg H; van Dalen EC
Cochrane Database Syst Rev; 2014 Jul; (7):CD009219. PubMed ID: 24984156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
